Zoetis (MEX:ZTS) Cyclically Adjusted Revenue per Share: MXN329.26 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:ZTS Zoetis Inc MEX:ZTS
71 GF Score
Price MXN1,266.00
GF Value MXN3,049.19
Valuation Significantly Undervalued
View Full Analysis

What is Zoetis Cyclically Adjusted Revenue per Share?

Zoetis MEX:ZTS +1.69% 71 Cyclically Adjusted Revenue per Share is MXN329.26 as of Jun. 2026. GuruFocus rates MEX:ZTS with a GF Score™ of 71/100 and a GF Value™ of MXN3,049.19 (Significantly Undervalued).

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Zoetis's adjusted revenue per share for the three months ended in Jun. 2026 was MXN103.098. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is MXN329.26 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Zoetis's average Cyclically Adjusted Revenue Growth Rate was 8.70% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 9.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Zoetis was 10.40% per year. The lowest was 7.90% per year. And the median was 9.00% per year.

As of today (2026-08-12), Zoetis's current stock price is MXN1266.00. Zoetis's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was MXN329.26. Zoetis's Cyclically Adjusted PS Ratio of today is 3.84.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Zoetis was 19.62. The lowest was 3.88. And the median was 11.63.


Zoetis  (MEX:ZTS) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Zoetis's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1266.00/329.26
=3.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Zoetis was 19.62. The lowest was 3.88. And the median was 11.63.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Zoetis Cyclically Adjusted Revenue per Share Related Terms


Zoetis Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Zoetis's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zoetis Cyclically Adjusted Revenue per Share Chart

Zoetis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 257.94 268.05 255.05 339.66 318.63

Zoetis Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 324.97 321.21 318.63 319.58 329.26

MEX:ZTS vs UTHR, VTRS, NBIX: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Zoetis's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zoetis Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zoetis's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Zoetis's Cyclically Adjusted PS Ratio falls into.


MEX:ZTS
71GF Score
Zoetis Inc MEX:ZTS
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zoetis Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Zoetis's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=103.098/333.9520*333.9520
=103.098

Current CPI (Jun. 2026) = 333.9520.

Zoetis Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 48.193 241.428 66.662
201612 53.027 241.432 73.348
201703 46.797 243.801 64.101
201706 46.434 244.955 63.304
201709 49.645 246.819 67.171
201712 58.405 246.524 79.118
201803 50.668 249.554 67.804
201806 57.034 251.989 75.585
201809 56.985 252.439 75.386
201812 63.384 251.233 84.253
201903 58.423 254.202 76.752
201906 61.613 256.143 80.329
201909 64.946 256.759 84.472
201912 65.740 256.974 85.433
202003 75.092 258.115 97.155
202006 74.736 257.797 96.814
202009 82.455 260.280 105.794
202012 75.077 260.474 96.256
202103 80.027 264.877 100.897
202106 81.293 271.696 99.920
202109 85.909 274.310 104.588
202112 84.848 278.802 101.632
202203 83.407 287.504 96.882
202206 87.555 296.311 98.677
202209 85.846 296.808 96.589
202212 85.212 296.797 95.879
202303 77.594 301.836 85.850
202306 80.738 305.109 88.370
202309 81.205 307.789 88.108
202312 81.647 306.746 88.888
202403 79.219 312.332 84.703
202406 94.855 314.175 100.826
202409 103.683 315.301 109.816
202412 107.124 315.605 113.351
202503 100.373 319.799 104.815
202506 104.564 322.561 108.257
202509 99.337 324.800 102.136
202512 98.006 324.054 101.000
202603 96.567 330.213 97.660
202606 103.098 333.952 103.098

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of MXN329.26 mean?
Zoetis (MEX:ZTS) has a Cyclically Adjusted Revenue per Share of MXN329.26 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Zoetis and its competitors.
Is Zoetis' Cyclically Adjusted Revenue per Share too high?
Zoetis' current Cyclically Adjusted Revenue per Share is MXN329.26. Overall, Zoetis has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zoetis' Cyclically Adjusted Revenue per Share compare to UTHR and VTRS?
Zoetis' Cyclically Adjusted Revenue per Share of MXN329.26 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Zoetis and its competitors. Zoetis's current Cyclically Adjusted Revenue per Share is MXN329.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zoetis stock overvalued right now?
Based on GuruFocus' analysis, Zoetis (MEX:ZTS) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN3,049.19, compared to a current price of MXN1,266.00 — trading 58.5% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is MXN329.26. Zoetis' overall GF Score™ is 71/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Zoetis (MEX:ZTS), the current Cyclically Adjusted Revenue per Share is MXN329.26 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zoetis (MEX:ZTS) Overvalued in 2026?

Based on GuruFocus' analysis, Zoetis stock appears to be undervalued. The current stock price of MXN1,266.00 is trading 58.5% below its estimated GF Value™ of MXN3,049.19. GuruFocus considers Zoetis to be Significantly Undervalued.

Key valuation signals for MEX:ZTS:

  • Cyclically Adjusted Revenue per Share: MXN329.26
  • GF Value™: MXN3,049.19 vs. price of MXN1,266.00 (58.5% below fair value)
  • GF Score™: 71/100

No single metric tells the full story. See the MEX:ZTS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zoetis Business Description

Address 10 Sylvan Way, Parsippany, NJ, USA, 07054
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
71GF Score

Get the complete analysis for MEX:ZTS

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,266.00
Price
MXN3,049.19
GF Value